Resources

Here you find The New Health Institute's selection of the most relevant resources.

How Parents’ Trauma Leaves Biological Traces in Children

Rachel Yehuda, 2022

Link to Resource

Ketamine for treatment-resistant major depressive disorder: Double-blind active-controlled crossover study

Paul Glue, Shona Neehoff, Ben Beaglehole, Shabah Shadli, Neil McNaughton, Natalie J Hughes-Medlicott, 2024

Link to Resource

Lysergic Acid Diethylamide–Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study

Holze, Friederike et al., 2023

Link to Resource

MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial

Mitchell, J.M., Ot’alora G., M., van der Kolk, B. et al., 2023

Link to Resource

On Revelations and Revolutions: Drinking Ayahuasca Among Palestinians Under Israeli Occupation

Leor Roseman, Nadeem Karkabi, 2021

Link to Resource

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Carhart-Harris RL, Bolstridge M, Rucker J, et al., 2016

Link to Resource

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial

Ross S, Bossis A, Guss J, et al., 2016

Link to Resource

The efficacy of ibogaine use in opioid use disorder compared to buprenorphine

Shuyi Lao, Danielle Carbonaro, Laura Schaffer, Kathlyn Larco, Colin Elie, Danielle Reynolds, 2019

Link to Resource

Advancing the Science & Application of Psychedelics to Improve Mental Health

The University of Texas at Austin, Dell Medical School

Link to Resource

Center for the Science of Psychedelics

UC Berkeley

Link to Resource

Inside Ibogaine, One of the Most Promising and Perilous Psychedelics for Addiction

Mandy Oaklander, 2021

Link to Resource

Center for the Neuroscience of Psychedelics

Massachusetts General Hospital

Link to Resource